Generic prices to fall by 46% over original brands

When a number of newly licensed generic drugs for GSK “Hepsera” (adefovir) or SK Chemicals “Joins” will get listed for insurance coverage in the months to come, their prices of the corresponding original drugs will be sharply decreased by 46 percent, according to the Korea Food and Drug Administration.

Under the current drug pricing system, when the patent period of an original drug expires,...